References
1. Koslow M, Kuperstein R, Eshed I, et al: The unique clinical features and outcome of infectious endocarditis and vertebral osteomyelitis co-infection. Am J Med. 2014, 127:669 e669-669 e615. 10.1016/j.amjmed.2014.02.023
2. Wang A, Gaca JG, Chu VH: Management Considerations in Infective Endocarditis: A Review. JAMA. 2018, 320:72-83. 10.1001/jama.2018.7596
3. Galar A, Weil AA, Dudzinski DM, et al: Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management. Clin Microbiol Rev. 2019, 32. 10.1128/CMR.00041-18
4. Murillo O, Grau I, Gomez-Junyent J, et al: Endocarditis associated with vertebral osteomyelitis and septic arthritis of the axial skeleton. Infection. 2018, 46:245-251. 10.1007/s15010-018-1121-9
5. Marek D, Sovova E, Kocianova E: The prevalence of eustachian valve on transoesophageal echo examination. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011, 155:283-285. 10.5507/bp.2011.025
6. Fan J, Le PTN, Jones BD: Eustachian valve endocarditis. Proc (Bayl Univ Med Cent). 2019, 32:572-573. 10.1080/08998280.2019.1646595
7. Toyoda N, Chikwe J, Itagaki S, et al: Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017, 317:1652-1660. 10.1001/jama.2017.4287
8. Pant S, Patel NJ, Deshmukh A, et al: Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015, 65:2070-2076. 10.1016/j.jacc.2015.03.518
9. Murdoch DR, Corey GR, Hoen B, et al: International Collaboration on Endocarditis-Prospective Cohort Study I: Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009, 169:463-473. 10.1001/archinternmed.2008.603
10. Youssef D, Marroush TS, Tanveer F: A case report of eustachian valve endocarditis due to Salmonella typhimurium in an AIDS patient. Germs. 2019, 9:154-157. 10.18683/germs.2019.1170
11. Habib G, Lancellotti P, Antunes MJ, et al: Group ESCSD: 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015, 36:3075-3128. 10.1093/eurheartj/ehv319
12. Casqueiro J, Casqueiro J, Alves C: Infections in patients with diabetes mellitus: A review of pathogenesis. Indian J Endocrinol Metab. 2012, 16 Suppl 1:S27-36. 10.4103/2230-8210.94253
13. Palakodeti V, Keen WD, Jr., Rickman LS, et al: Eustachian valve endocarditis: detection with multiplane transesophageal echocardiography. Clin Cardiol. 1997, 20:579-580. 10.1002/clc.4960200613
14. Sawhney N, Palakodeti V, Raisinghani A, et al: Eustachian valve endocarditis: a case series and analysis of the literature. J Am Soc Echocardiogr. 2001, 14:1139-1142. 10.1067/mje.2001.114012
15. Kim MJ, Jung HO: Anatomic variants mimicking pathology on echocardiography: differential diagnosis. J Cardiovasc Ultrasound. 2013, 21:103-112. 10.4250/jcu.2013.21.3.103
16. Gad A, Mannan J, Chhabra M, et al: Prominent Eustachian Valve in Newborns: A Report of Four Cases. AJP Rep. 2016, 6:e33-37. 10.1055/s-0035-1565920
17. ElRefai M, Thananayagam K, Bathula R, et al: An Unusual Cause of Cardioembolic Stroke: Paradoxical Embolism Due to Thrombus Formation on the Eustachian Valve. Echocardiography. 2015, 32:1588-1591. 10.1111/echo.12945
18. Kremers HM, Nwojo ME, Ransom JE, et al: Trends in the epidemiology of osteomyelitis: a population-based study, 1969 to 2009. J Bone Joint Surg Am. 2015, 97:837-845. 10.2106/JBJS.N.01350
19. Fraenkel PG: Anemia of Inflammation: A Review. Med Clin North Am. 2017, 101:285-296. 10.1016/j.mcna.2016.09.005
20. Koury MJ, Haase VH: Anaemia in kidney disease: harnessing hypoxia responses for therapy. Nat Rev Nephrol. 2015, 11:394-410. 10.1038/nrneph.2015.82
21. Park KH, Cho OH, Lee JH, et al: Optimal Duration of Antibiotic Therapy in Patients With Hematogenous Vertebral Osteomyelitis at Low Risk and High Risk of Recurrence. Clin Infect Dis. 2016, 62:1262-1269. 10.1093/cid/ciw098